A bacteriological study of isolates from the oral cavity of patients with Kawasaki disease (KD), age-matched non-KD patients and healthy children, showed that over half the KD and control isolates had gram-positive, catalase-negative cocci. About 50 % of these organisms were identified as viridans streptococci by means of an API Strep 20 kit. Further identification by fluorometric DNA-DNA hybridisation demonstrated that the predominant species were S. oralis and S. mitis, each of which accounted for 25 YO of the isolates of viridans streptococci ; 40 YO of viridans strains were unidentifiable ; and S. sanguis and S. parasanguis were minor components. Studies in vivo showed that insertion of culture supernates of most of the viridans streptococci increased capillary permeability and induced redness with swelling and occasional bleeding in rabbit skin. One-third of S. mitis strains and one-fifth of the unidentified strains caused aggregation of human blood platelets, whereas S. oralis and other strains had no such effect. The distribution of extracellular lipoteichoic acids and glucan produced in the presence of sucrose was also examined. There were no significant differences in the recovery rate of viridans streptococci forming these biologically active extracellular products between KD and control groups.
Introduction
The epidemiological features, clinical symptoms and laboratory findings of Kawasaki disease (KD)-acute febrile, mucocutaneous, lymph node syndrome-have suggested that a possible cause is an infectious organism' resident in the oral cavity or throat whose toxic and biologically active products are capable of causing immunological disorders and inflammatory reaction^.^-^ However, several attempts to identify a specific microbe that would satisfy Koch's postulates, particularly one recoverable exclusively from KD patients, have so far failed. So we speculated that the causative agent of KD is either an organism that cannot be isolated by conventional techniques or an agent that requires other factors to produce clinical symptoms and signs as well as pathological changes.
As the first step in a study based on the hypothesis that oral or throat bacteria capable of producing biologically active factors are involved in the pathogenesis of KD, we attempted to isolate a significant taken from the throat and tooth surfaces of 89 patients with KD during the acute phases, 2-5 days after onset, and before intravenous gammaglobulin therapy, from 17 children with other febrile diseases and from six healthy children.
Isolation procedures and classification of clinical isolates
Swabs were transported promptly from the clinic to the laboratory in C0,-enriched anaerobic transport medium (Kenki Porter, Clinical Supply, Gifu, Japan). Microbes on the swabs were transferred to GAM semi-solid medium (Gifu Anaerobic Medium, Nissui Corp., Tokyo, Japan) and cultured at 37°C for 24-48 h. Bacteria were streaked on pairs of Columbia Sheep Blood Agar plates (bioMerieux, Marcy L'Etoile, France). One of each pair was cultured aerobically and the others were incubated anaerobically in jars made anaerobic with the Gas Pak system (Becton Dickinson Microbiology System, Cockeysville, MD, USA) at 37°C for 24 h. Representative single colonies on the blood-agar plates in Gas Pak jars were selected, streaked again on blood agar plates and cultured aerobically at 37°C for 24 h. The fact that virtually 100 % recovery was achieved by this method indicated that all bacteria grown in the Gas Pak can grow aerobically. The strains obtained in pure culture were inoculated in GDO (Groups of Difficult Organisms) medium (Nissui Corp.) devised to store groups of " difficult organisms " and stored at -20°C until use.
The isolates were cultured aerobically on bloodagar plates at 37°C for 18 h, and the bacteria that had grown were stained by Gram's method. Gram-positive cocci were then checked by the catalase test,s and divided into catalase-positive and -negative groups. Gram-negative rods were divided into oxidase-positive and -negative groups. Bacterial strains isolated from KD patients and control children were thus broadly divided into the following genera and groups.
(1) Micrococcus and Staphylococcus (gram-positive, catalase-positive cocci) ; (2) Streptococcus, Enterococcus and Lactococcus (gram-positive, catalase-negative cocci) ; (3) Bacillus and Corynebacterium (grampositive bacilli) ; (4) Neisseriaceae (gram-negative cocci) ; ( 5 ) Non-fermenting gram-negative bacteria (gram-negative, oxidase-positive bacilli) ; (6) Enterobacteriaceae (gram-negative, oxidase-negative bacilli).
We concentrated on group 2 described above, which accounted for more than half of all isolates from both KD and control children (table I): 98 and 27 strains derived from clinical specimens from 22 patients with KD and 11 with other febrile diseases, respectively, collected at the Department of Pediatrics, Japan Red Cross Medical Center (Tokyo) in 1990-1991 were identified according to the manufacturer's manual for the API Strep 20 kit (bioMirieux, LaBalme les Grottes, France) and the Analytical Profile Index.
Identification of viridans group streptococci by jluorometric DNA-D NA h ybridisa tion
Gram-positive, catalase-negative a-haemolytic cocci classified into three groups, S. sanguis 11, S. sanguis I1 or S. pneumoniae and S. mitis (see table 11 ) were identified by fluorometric hybridisation in microdilution wells.'-' Reference strains S. mitis ATCC903, ATCC6249 and ATCC 1 59 1 1, S. oralis ATCC98 1 1 and S. parasanguis ATCC 1 5909 were also identified by this method. The type strains were as follows: S. dysgalactiae NCFB2023, S. suis NCTC 1.0234, S. pneumoniae NCTC7465, S. oralis NCTCll427, S. mitis NCTC12261 (neotype), S. sanguis ATCC10556, S. parasanguis ATCC 1 59 12, S. gordonii NCTC7865, S. salivarius ATCC7073, S. intermedius ATCC27335 and Escherichia coli K-12. A 100-pl volume of heatdenatured reference DNA (10 pg/ml) in phosphatebuffered saline (PBS), pH 7-2, containing 0.1 M MgCl, was incubated for 1 h at 37°C in a microdilution well (MicroFluor " B " plate, Dynatech Laboratories Inc., Alexandria, VA, USA). The solution was removed and the plate was dried at 45°C for several hours to immobilise the DNA. A 200-p1 volume of pre-hybridisation solution containing 200 pg of denatured salmon sperm DNA (Sigma) was added to each well and incubated at 45°C for 1 h. The pre-hybridisation solution was discarded and replaced with 1OOpl of hybridisation solution containing 10-20 ng of biotinylated DNA of clinical isolates/well. Hybridisation proceeded for 2 h at 45°C. The wells were washed three times with PBS containing Triton XlOO 0.1 YO (PBS-T). One hundred pl of 0.3 U/ml of streptavidinconjugated P-D-galactosidase (Zymed Laboratories Inc., San Francisco, CA, USA) dissolved in PBS-T containing bovine serum albumin 2 YO (PBS-BSA-T) were added to the wells and incubated at 37°C for 15 min. The plate was washed with PBS-T and a 50 p1 volume of 3 x M methylumbelliferyl-~--o-galactopyranoside (Koch-light Ltd, Haverhill, Suffolk) in PBS-BSA was added to each plate. After incubation at 30°C for 30min, the intensity of developing fluorescence was measured with a Micro Fluor reader (Dynatech Laboratories Inc.) at a wavelength of 360 nm for excitation and at 450 nm for emission. The intensity of fluorescence in the well containing salmon sperm DNA was taken at zero, and in the well that emitted the strongest fluorescence this was taken as 100%. E. coli DNA served as a negative control.
When the second highest intensity was < 70 YO and the ratio of the maximum :control value > 5, a test strain was identified as being of the same species as the type strain that gave the greatest intensity.
Preparation of culture supernate concentrate
Test strains of viridans streptococci were cultured in 5 ml of a chemically defined medium (CDM)l0 at 37°C for 18 h in a CO, 5 YO incubator. Each growth was transferred to a flask containing 500 ml of CDM and Into the depilated dorsal slun of albino, female domestic rabbits weighing c. 2.5 kg (Nippon Biosupply Centre, Tokyo) 0.1 ml of test specimens, containing protein 0.8-1.0 mg/ml in 0.15 M PBS, was injected intradermally at intervals. Skins were then examined for redness, swelling and bleeding. After the final intradermal injection, the rabbits were given an intravenous injection of aqueous Evans blue 1-0 YO. After 30 min, the rabbits were killed, the skin was dissected from the abdominal wall and turned inside out to look for any blue colour due to dye leakage (an indication of increased capillary permeability), and bleeding of the test skin sites.12 A piece of skin was fixed with formalin, embedded in paraffin and stained with haematoxylin and eosin (H and E) by conventional procedures. The intensity of blue dye and redness with swelling, with or without bleeding was scored macroscopically as -, + or + +.
Blood platelet aggregation
Human peripheral blood was obtained from only one adult female donor (YT) throughout the study. Nine volumes (either 4.5 or 9.0 ml) of peripheral blood were drawn into a syringe containing one volume (0.5 or 1-0 ml) sodium citrate 3.8 YO. Platelet-rich plasma (PRP) was obtained by centrifugation of the citrated blood at 170 g for 10 min at 20°C. Aggregation of a mixture consisting of 200 p1 of PRP and 20 pl of a test or a reference specimen was determined at 37°C with a two-channel aggregometer (Model PAT-2A, Nikko Bioscience Ltd, Tokyo) attached to a tracer (Model T-228, Nikko Bioscience Ltd). Adenosine 5'-diphosphate (ADP, Sigma) in saline 0.85 % ( M) served as the reference aggregation agent. The aggregation activity was measured 7 min after the addition of a test or reference specimen to the PRP. The potency of ADP in terms of increased light transmission of the reaction mixture was taken as loo%, and that of each test specimen was expressed as a percentage of that of ADP. Values > 10 c 50% were scored +, and those > 50 YO, + + ; values c 10 % were discarded.
Haemoly t ic activity
A mixture of 50-pl volumes of a test specimen and a sheep red blood cell (SRBC) 2 YO suspension in 0.01 M PBS, pH 7.2, was examined for haemolysis on a microtitration plate (Nunc, Roskilde, Denmark) after incubation overnight at room temperature. Complete and partial haemolysis were scored as + + and +, respectively. Marginal haemolysis was designated .
Detection of lipoteichoic acids
An antiserum to lipoteichoic acid (LTA) was prepared by immunising albino female rabbits (Nippon Biosupply Centre) weighing c. 3.0 kg with lyophilised Enterococcus hirae (E. faecalis, ATCC9790) whole cells (a gift from Dr K. Kato, School of Dentistry, Okayama University, Okayama, Japan). This was done as follows. Rabbits received foot-pad injections four times at 10-day intervals with 10mg of whole cells, of E. hirae suspended in 0.01 M PBS, pH 7-2, and emulsified in Freund's complete adjuvant (Difco). An anti-LTA serum was obtained 10 days after the fourth injection, and semi-quantified at the anti-LTA antibody level by a passive haemagglutination test (PHA).13 Two-fold dilutions (25 pl) of the anti-LTA serum were dispensed into the wells of U-bottomed, 96-well microtitration plates (Nunc), followed by 25 pl of an SRBC suspension (2 YO in PBS, pH 7.2) sensitised with E. faecalis LTA (Sigma). The haemagglutinating titre of one representative rabbit immune serum was 1 in 5120.
A mixture of equal amounts of the test specimen and a 1 in 320 dilution of the above rabbit antiserum was incubated for 2 h at 37°C and overnight at 4°C. A supernate of the mixture was incubated with an equal volume of a 2% suspension of SRBC sensitised with LTA for 3 h at room temperature, to determine the haemagglutination inhibition effects of the test specimens. The minimum inhibitory doses of reference strain E. hirae LTA-2 (diacyl-[phosphatidylkojibiosyl] glycerol) and a polyglycer~phosphate~~ (a gift from Dr K. Kato) were 20 and 500pg/ml, respectively. The LTA content of the test specimens, with and without LTA, was graded semi-quantitatively into complete (+ +), partial (+) and no inhibition (-).
Glucan production
Test strains were cultured in Brain-Heart Infusion Broth (Nissui Corp.) at 37°C for 18 h, and one drop of the growth was inoculated into 4ml of Tryptic Soy Broth (Difco) supplemented with sucrose 5 %. 15 After incubation for 48 h at 37OC, the supernate was separated by centrifugation at 1500 g for 20 min and mixed with an equal volume of absolute ethanol. The resulting turbidity and precipitation due to soluble glucan in the culture supernate were compared with the non-inoculated control medium which was similarly treated. Glucan production was expressed as either positive (+) or negative (-).
Antibiotic susceptibility of test and reference viridans streptococci
Disks (TridiskR, Eiken Kagaku Co. Ltd, Tokyo) containing various antimicrobial agents were applied to the surface of Mueller-Hinton S Disk Agar (Eiken Kagaku Co. Ltd) plates which were inoculated with 0.1 ml of a culture containing c. los cfu/ml from KD patients or control subjects and of reference type strains. After incubation for 20 h at 37"C, the plates were examined for inhibition of growth around the disks, according to the manufacturer's instructions.
When the inhibitory zone was > 1 mm, the streptococci were taken to be sensitive. Antibiotics 
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Bacterial isolates from KD patients and control children
S. mitis were further identified by fluorometric DNA-
Ident $cat ion of gram-posit iue, catalase-nega t ive cocci
Ninety-eight strains of gram-positive, catalasenegative cocci isolated from 22 KD patients and 27 strains from 11 control children were identified according to their biochemical activities with an API Strep 20 kit (table 11); 18% of strains from KD patients and 3 3 % of those from control individuals were assigned to S. sanguis I1 (including S. sanguis I1 or S. pneumoniae group) and 35 and 26 YO of the isolates from KD and control children were identified as S . mitis, respectively. (Hereafter these streptococci will be collectively referred to as viridans streptococci.) The remainder belonged to miscellaneous species (table 11) .
DNA hybridisation (table 111) . Nearly half (12 of 27 strains) of the S. sanguis I1 group, irrespective of source, were identified as S. oralis, and then S. mitis, S. sanguis and S. parasanguis, in that order. One-third of biochemical S. sanguis I1 strains were unidentifiable. The predominant species (13 of 41 strains) in the biochemical S. mitis group was identified genetically as S. mitis, followed by S. oralis, but nearly half the biochemical S. mitis strains could not be identified genetically. Thus, 13 (25 YO) and 12 (23 YO) strains of 52 isolates from KD patients were identified as S. o r a h and S. mitis, respectively. Among those from the control children, four (25 YO) and five (3 1 YO) of 16 were S. oralis and S. mitis, respectively. Viridans streptococci used as reference strains, namely S. mitis ATCC903, S. mitis ATCC6249 and S. mitis ATCCl59 1 1 were identified as S. parasanguis, S. oralis and S. parasanguis, respectively, and both S. oralis ATCC98 1 1 and S. parasanguis ATCC 1 5909 were identified as S. oralis.
Biological activities of extracellular products of isolates of viridans streptococci from KD patients and control children
Induction of increased capillary permeability and vasculitis in rabbit skin. As shown in table IV, culture supernate concentrates of 88 % of KD strains caused increased capillary permeability without bleeding for between 5 min and 3 h after intradermal injection. The culture supernate concentrates of all 16 strains from control subjects and those of seven reference strains also caused an increase in capillary permeability. The enhanced capillary permeability in the rabbit skin by test and reference viridans streptococci was followed by redness, swelling and sometimes bleeding after a few hours and up to 48 h; this lasted for 4 days in some animals. The two type strains, S. sanguis ATCC10556 and S. gordonii NCTC7865, did not produce these signs.
Histological examination of the test skin sites showing the early reaction revealed increased dilatation of the veins and capillaries in the dermis, but no infiltration of inflammatory cells ( fig. 1) . The lesions in the later stages of the reaction were characterised by extravasation of many neutrophils along dilated veins, where the endothelial cells appeared to be hypertrophic. Perivascular fibroblasts increased in number and their cytoplasm was hypertrophic (fig. 2) . Massive infiltration of neutrophils occasionally resulted in foci of abscess-like changes (not shown).
Human blood platelet aggregation and SRBC haemolysis. Table IV shows that (25%) three of 12 S. mitis t Drug content &g disk).
strains from KD and (40 YO) two of five S. mitis strains from control aggregated YT blood platelets, whereas none of 17 S. oraZis strains from KD and control subjects caused significant aggregation ( fig. 3) . Culture supernate concentrates of seven test strains of S. sanguis and S. parasanguis were inactive in this assay, but six (22%) of 27 strains whose species remained unknown, were powerfully active. Seven reference uble glucan in the medium supplemented with sucrose was almost confined to S. oralis strains, (69 YO) nine of 13 KD strains and (25 YO) one of four control strains.
Only exceptional strains of viridans streptococci other than S. oralis produced extracellular glucan. Three of seven reference or type strains gave positive results in this test (table IV) .
strains did not form extracellular products capable of causing platelet aggregation. (table IV) .
Glucan production. Production of extracellular, solAll 68 fresh isolates of viridans streptococci, irrespective of species or source, showed greater resistance to six test antimicrobial drugs compared with serially subcultured reference strains. This was particularly true with cephalosporins such as cephalexin and cefaclor with erythromycin. Acquisition of resistance to other drugs, particularly the broad-spectrum semi-synthetic p-lactam agents such as ampicillin and amoxycillin, was minimal (table V) .
Discussion
This study showed that a major group of bacteria isolated from the oral cavity of KD patients and non-KD control children included S. sanguis I1 (S. sanguis I1 or S. pneumoniae) and S. mitis, identified by biochemical tests, although the taxonomy of these viridans streptococci has not yet been finally estab-lished.ls-ls Initially, we tried to identify the viridans streptococci by fluorometric DNA-DNA hybridisat i~n ,~ with 10 type strains as reference strains. When the homology value between the test and the type strain was > 70 YO, a test strain was identified as being of the same species as the respective type strain. The isolates homologous with several type strains were unidentified. No KD-specific bacteria were identified by DNA hybridisation studies. The novel finding in the present study was that during growth many viridans streptococci released biologically active, extracellular products that were responsible for increased capillary permeability, erythrogenic activity, human blood platelet aggregation and SRBC haemolysis, as well as production of LTA and glucan. However, there were no significant differences in the isolation rates of the viridans streptococci producing biologically active extracellular products between KD patients, agematched non-KD patients and healthy children.
The ability to aggregate human blood platelets was much more restricted to the culture supernate concentrates of a limited number of viridans streptococci than other effects such as changes in rabbit skin. However, there were no significant differences between KD and control isolates in the isolation rates of viridans streptococci whose culture supernates caused blood platelet aggregation. A preliminary study demonstrated that there are significant individual differences in the susceptibility of platelets to aggregation factor in the culture supernate amongst members of one S. mitis strain (strain Nm-65).
Human platelet aggregation and SRBC haemolytic activity correlated well. Nearly all the culture supernates that caused platelet aggregation haemolysed SRBC, although the reverse was not necessarily true. Nevertheless, our attempt to purify a platelet aggregation principle revealed that a fraction causing strong platelet aggregation activity was distinct from a concentrate that haemolysed SRBC, by DEAE column chromatography (unpublished data).
Studies on biologically active, extracellular products of viridans streptococci are limited, but there are several studies on viridans streptococci associated with subacute bacterial endocarditis (SBE). Proteases have been identified in culture supernate of S. mitis, S. sanguis, S. mutans, S. salivarius and S.MG intermedius isolated from confirmed cases of SBE;l9. 2o extracellular neuraminidase is produced by a S. sanguis strain associated with SBE,21 and an immunoglobulin A1 degrading enzyme has been reported as an extracellular product of oral streptococci such as S. sanguis, S. mitis and S. oralis. 22 The interaction between human platelets and S. sanguis whole cells was studied by Herzberg et al.,23-25 to elucidate the pathological mechanisms in SBE. They observed that the interaction was mediated by two or more antigens in the fibrillar surface appendages and showed that one antigen designated as the class I component bound with the platelets, that the other antigen (class I1 component) triggered platelet aggregation and that the class I1 component shared a cross-reactive immunodeterminant with 27 Consequently, the extracellular platelet aggregation factor reported here may be of bacterial cell-surface origin. However, a recent study showed that YT platelets thoroughly washed with ACD (citric acid-0-8 YO w/v sodium citrate-2.2 % w/v glucose 2.2 % w/v), to remove blood plasma components, and resuspended in ACD-0.0 1 M PBS (pH 8.5) were aggregated by a test extracellular aggregation factor (unpublished data). As Sullam et a1. 28 reported that plasma components were needed for platelet aggregation by whole S. sanguis and S. salivarius cells, the mechanism of platelet aggregation by the culture supernate concentrates described here may differ from that of whole bacterial cells.
Because of the reported immunobiological activity of E. faecalis (E. hirae) LTA,I4 the distribution of extracellular LTA in viridans streptococci was examined. Extracellular LTA may be LTA which was originally associated with the cell walls before being released extracellularly in a manner similar to the extracellular glycoprotein antigen of some S. sanguis species. 29 Regarding the correlation between the human platelet aggregation and the presence of extracellular LTA, the fact that the LTA-containing culture supernates of a few test strains did not show any aggregation excludes the possibility that the platelet aggregation is due to extracellular LTA. Indeed, a report that the LTA of group A streptococci bound to human blood platelets but did not cause platelet aggregati~n,~~ suggests the opposite. The extracellular LTA of some viridans streptococci bound to the platelets and may have interfered with platelet aggregation.
A recent study by Furusho et aL31 showed that an insoluble glucan produced by S. sanguis, particularly in the presence of detergent, stimulated interleukin-1 a production in human monocyte cultures, and prompted us to investigate the production of extracellular (soluble) glucan by viridans streptococci. Most genetically identified S. oralis but none of the S. mitis strains produced glucan extracellularly. No correlation was found between glucan production, platelet aggregation, haemolytic activity and the existence of LTA.
Viridans streptococci freshly isolated from KD patients and control children in general showed greater resistance to the antibiotics commonly prescribed for paediatric patients, especially to the cephalosporins and erythromycin, than the type culture strains.
We also demonstrated that erythrogenic culture supernates of two representative strains of S. oralis and S. mitis were capable of inducing serum tumour necrosis factor-a (TNF-a), interleukin-6 (IL-6) and gamma interferon (INF-y) by administration into appropriately primed mice (Takada et al., unpublished observations). The concentrate also induced TNF-a, IL-6 and a thymocyte activating factor (TAF, essentially IL-1) in murine peritoneal macrophages and human monocyte cultures. Partially purified " toxin" fractions (F-1 and F-2) were obtained from the culture supernate of one S. mitis strain. The erythrogenic F-1 fraction induced high levels of serum TNF-a, IL-6 and IFN-y in mice, and stimulated human peripheral whole blood to produce the above cytokines. This fraction also induced TAF and IL-6 activity in human umbilical vascular endothelial cells (HUVEC) and gingival fibroblast cultures. On the other hand fraction F-2, which increases capillary permeability but is not erythogenic to rabbit skin, functions as a class I1 histocompatibility antigen-restricted T-cell stimulator to induce interleukin-2 (IL-2), as a super-antigen on human lymphoid cells (Fujikawa et al., unpublished observations). Furukawa et al. further showed that fraction F-1, but not F-2, caused increased expression of intercellular adhesion molecule-1 and endotheliumlymphocyte adhesion molecule-1 on HUVEC,
